Condensed Consolidated Statements Of Cash Flows (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Jan. 24, 2014	Jan. 25, 2013
Operating Activities:
Net income (loss)	$ 53,553	$ 55,029
Adjustments to reconcile net income (loss) to net cash (used in)/provided by operating activities:
Depreciation	26,098	18,933
Amortization	2,044	1,636
Stock-based compensation	4,708	7,954
(Gain)/loss on asset divestitures	(2,857)	(2,071)
Changes in certain assets and liabilities, net of effects of acquired businesses:
(Increase)/decrease in accounts and notes receivable	102,823	100,104
(Increase)/decrease in inventories and other assets	(81,254)	(59,169)
Increase/(decrease) in trade accounts payable and other accrued liabilities	(90,387)	(126,637)
Increase/(decrease) in income taxes payable	407	4,087
Increase/(decrease) in other deferred liabilities	(6,657)	5,295
Other	839	(3,297)
Net Cash (Used In)/Provided By Operating Activities	9,317	1,864
Investing Activities:
Purchases of property, plant and equipment	(20,991)	(13,950)
Acquisition of businesses, net of cash acquired	0	(34,811)
Divestiture of businesses	4,716	0
Cash proceeds on disposal of assets	23	1,796
(Increase)/decrease in restricted cash	309	14
Net Cash (Used In)/Provided By Investing Activities	(15,943)	(46,951)
Financing Activities:
Net change in other borrowings	(22,910)	(3,896)
Net proceeds (repayments) of commercial paper	93,419	120,972
Proceeds from sale of treasury stock	1,588	9,832
Treasury stock purchases	(69,178)	(72,992)
Excess tax benefit from stock-based compensation	5,154	8,643
Dividends paid	(22,226)	(20,679)
Net Cash (Used In)/Provided By Financing Activities	(14,153)	41,880
Increase/(Decrease) in Cash and Cash Equivalents	(20,779)	(3,207)
Effect of exchange rate changes on Cash and Cash Equivalents	(2,780)	(1,478)
Cash and Cash Equivalents at Beginning of Period	216,150	253,327
Cash and Cash Equivalents at End of Period	$ 192,591	$ 248,642